By the end of 2013, there were 35 million people living human immunodeficiency virus (HIV) globally, and that number likely increased in subsequent years. However, the clone of a potent single-cell-based antibody, that...
Results from a new trial found that an “extremely potent” antibody can dramatically reduce the level of the HIV virus in a patient’s blood — raising hopes for an HIV vaccine. Researchers at Rockefeller...